Literature DB >> 28508941

[Unusual tumor of the kidney].

C Lang1, J Schwerfeld-Bohr2, T Ebel3, D Kröpfl2, S Krege2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28508941     DOI： 10.1007/s00120-017-0390-8

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  5 in total

Review 1.  Complications of intravesical therapy for urothelial cancer of the bladder.

Authors:  Madhusudan P Koya; Michael A Simon; Mark S Soloway
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

2.  [Practical guideline for the management of adverse events associated with BCG installations].

Authors:  Fernando Rodríguez; Juan Palou; R Martínez; O Rodríguez; A Rosales; Jorge Huguet; Humberto Villavicencio
Journal:  Arch Esp Urol       Date:  2008-06       Impact factor: 0.436

3.  Duplex detection of the Mycobacterium tuberculosis complex and medically important non-tuberculosis mycobacteria by real-time PCR based on the rnpB gene.

Authors:  Guma Abdeldaim; Erik Svensson; Jonas Blomberg; Björn Herrmann
Journal:  APMIS       Date:  2016-09-28       Impact factor: 3.205

4.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 5.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.